Boston, Massachusetts–(Newsfile Corp. – June 10, 2025) – Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today…Read More

You might also be interested in reading Start-up CGU Raises $2.5 Million USD in Third Public Round.